President's Message

It is a great honor to have been appointed President of the Japan Pharmaceutical Manufacturers Association (JPMA). First and foremost, I would like to express my deepest respect for the immense contributions of all those who have dedicated themselves to the development of the Japanese pharmaceutical industry, and my sincere gratitude for the opportunity to undertake this significant responsibility.

The mission of pharmaceutical companies is to leverage the most advanced scientific technologies to develop new drugs with higher efficacy and assured safety, and to deliver them promptly and consistently to patients in need. The discovery and development of innovative medicines not only provides new treatment options but also contributes to the optimization of health care costs and the improvement of patients’ Quality of Life (QOL). In recent years, groundbreaking new drugs have been successively emerging in fields such as cancer, rare diseases, and dementia, and we aim to further accelerate research and development of innovative new drugs.

The societal value of pharmaceuticals and the potential of the industry are also emphasized in the Japan’s growth strategy. In addition to revitalizing the domestic market, promoting Japan’s advanced technologies through global expansion will contribute to the sustainable growth of the national economy. Particularly with the growth of emerging markets, primarily in Asia, we believe that the significance of Japanese pharmaceutical companies increasing their presence in these regions will continue to grow.

Central to JPMA’s industry vision is the concept of “Co-creation” from a patient perspective, aiming to realize “patient and citizen-participatory drug discovery” and, beyond the scope of drug discovery, to achieve a sustainable society where all citizens can live long and healthy lives. To achieve this, it is indispensable to promote healthcare digital transformation through the utilization of medical data and AI. We will continue to engage in dialogue with various stakeholders, including patients, government, healthcare professionals, and academia, to jointly create new value for society, thereby guiding Japanese healthcare in a better direction.

Our ultimate goal as pharmaceutical companies is to bring about a society where all people can lead healthy and prosperous lives. We will further promote innovation in the pharmaceutical industry to establish a sustainable social security system and contribute to the development of Japanese healthcare and economy.

TOP